Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) EBT (2019 - 2025)

Outset Medical (OM) has disclosed EBT for 7 consecutive years, with -$19.4 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 24.36% to -$19.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$80.9 million, a 36.51% increase, with the full-year FY2025 number at -$80.9 million, up 36.51% from a year prior.
  • EBT was -$19.4 million for Q4 2025 at Outset Medical, down from -$17.4 million in the prior quarter.
  • In the past five years, EBT ranged from a high of -$17.4 million in Q3 2025 to a low of -$46.1 million in Q3 2023.
  • A 5-year average of -$33.8 million and a median of -$35.5 million in 2022 define the central range for EBT.
  • Peak YoY movement for EBT: tumbled 45.21% in 2021, then skyrocketed 46.25% in 2025.
  • Outset Medical's EBT stood at -$41.1 million in 2021, then decreased by 0.66% to -$41.4 million in 2022, then rose by 6.99% to -$38.5 million in 2023, then skyrocketed by 33.38% to -$25.6 million in 2024, then increased by 24.36% to -$19.4 million in 2025.
  • Per Business Quant, the three most recent readings for OM's EBT are -$19.4 million (Q4 2025), -$17.4 million (Q3 2025), and -$18.4 million (Q2 2025).